Henlius and OncoHost partner to predict trial outcomes using machine learning
OncoHost’s PROphet platform will build patient selection and outcome profiles in the Phase III trial of serplulimab for small-cell lung cancer.
Artificial Intelligence
Aiosyn launches new AI kidney suite for renal disease research
Brainomix and TIPAL partner to assess e-Lung platform
Astellas and Eko Health sign agreement for CORE 500 digital stethoscope
Sensome and Asahi Intecc partner on smart guidewire development
Ezra wins FDA approval for new AI tech to improve brain imaging
Paige launches new AI-driven digital assay for colon cancers
Leading AI companies for the medical device industry
